Centre de recherche du centre hospitalier de l'Université de Montréal (CRCHUM)

Montreal, Quebec H2X 3J4

1 studies enrolling now · 6 studies all time

What they study most

Enteric Hyperoxaluria, Lupus Nephritis, Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis With Liver Fibrosis, PSC, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis

Studies at this site

• Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study) — Recruiting now
• A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old — Completed
• Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment. — Running, not enrolling
• Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC) — Completed
• Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) — Completed
• Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria — Completed